The group’s principal activity is to provide disease management services. The group's provides services to diabetes disease management through the creation and commercialization of the sensys glucose tracking system (Sensys GTS) and non-invasive blood glucose measurement device. The group specializes in credentials spectroscopy, statistics, chemistry, engineering, finance, information technology and management. The group was founded in 1995. The group operates from the United States.
